je.st
news
Tag: collaboration
New Collaboration On Future Energy
2015-10-09 03:31:37| oilandgasonline Home Page
The Norwegian University of Science and Technology (NTNU) and Statoil recently (Thursday 1 October) signed an agreement on research funding for future energy solutions.
Tags: future
energy
collaboration
Movado Announces Exciting new Collaboration with Industrial Designer Yves Behar
2015-10-06 19:18:47| Jewelry - Topix.net
Uniting the talents of two of the most important industrial designers of the last 70 years, "I met Yves at the Aspen Ideas Conference in 2013 and we immediately connected through our deep appreciation of design," said design-focused vision was a compelling prospect for Movado and we are extremely proud of the result. The Movado Edge collection offers a stunning new interpretation of Movado's iconic signature - it is so distinctly and uniquely Movado, we decided we did not need to include the logo on the dial."
Tags: industrial
collaboration
designer
exciting
Dow AgroSciences, Synthace Research Collaboration To Accelerate Product Development Using High Tech Tools
2015-10-05 03:59:44| chemicalonline Home Page
Synthace and Dow AgroSciences LLC, a wholly owned subsidiary of The Dow Chemical Company, recentlyannounce they have entered into a research collaboration to optimize technology by accelerating development of fermentation-based production of crop protection products. This Smart News Release features multimedia
Tags: high
product
tools
research
Mark Parker: Details In Collaboration
2015-10-02 21:20:46| Footwear - Topix.net
Successful business has often benefited heavily from strategic collaborations. Supplementing deficiencies and tapping into new markets are key byproducts from properly executed partnerships.
Tags: details
mark
collaboration
parker
Merck and DNAtrix Announce Phase 2 Immuno-Oncology Collaboration in Patients with Aggressive Form of Brain Cancer
2015-10-01 14:00:00| Merck.com - Product News
Dateline City: KENILWORTH, N.J. & HOUSTON KENILWORTH, N.J. & HOUSTON--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, and DNAtrix today announced they have entered into an oncology clinical study collaboration to evaluate the efficacy and safety of DNX-2401, DNAtrixs oncolytic immunotherapy, in combination with KEYTRUDA (pembrolizumab), Mercks anti-PD-1 therapy, in a Phase 2, multi-centered study of patients with recurrent glioblastoma, the most aggressive form of brain cancer for which there is no cure. Language: English Contact: MerckMedia Relations:Pamela Eisele, 267-305-3558orAn Phan, 908-255-6325Investor Relations:Teri Loxam, 908-740-1986Justin Holko, 908-740-1879orDNAtrixInvestor/Media Relations:Imran Alibhai, Ph.D.ialibhai@dnatrix.com Ticker Slug: Ticker: MRK Exchange: NYSE read more
Sites : [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] next »